Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Atlassian Corporation PLC (TEAM) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Atlassian Corporation PLCTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Atlassian Corporation PLC vs Vir Biotechnology Inc. Common Stock — how do they compare? Atlassian Corporation PLC trades at $201.99 (market cap $52.66B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Atlassian Corporation PLC is far larger — about 29.3× Vir Biotechnology Inc. Common Stock's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Atlassian Corporation PLC for 65 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TEAMVIR
Market Cap
$52.66B$1.80B
Volume
2,601,3291,782,836
Sector
TechnologyHealth
52-Week High
$208.04$11.78
52-Week Low
$57.15$5.12
Typical Hold Time
65 Days0 Days
Enterprise Value
$52.66B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Atlassian Corporation PLC

Atlassian (TEAM) trades at $204.66, down 1.49% on the day, with a bullish technical signal from moving averages but overbought short-term RSI. The company shows strong revenue growth, improving net losses, and consistent earnings beats, though profitability metrics remain negative. Recent news highlights AI-driven growth catalysts and cloud momentum.

The outlook is positive given analyst consensus and AI adoption, but high valuation ratios and persistent net losses pose risks. Upside is supported by a large addressable market and subscription growth, while competition and execution challenges are key concerns for investors.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TEAM
49% Buy51% Sell
Avg holding period · 65 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Atlassian Corporation PLC

Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.

Read more on TEAM →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →